Location: Boston, MA
CIK: 0001583977 · Show all filings
Period: Q1 2019 (← Previous) (Next →)
Filing Date: May 15, 2019
Total Value: $1.48B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| IFRX | INFLARX NV | 2,590,000 | $97.88M | 6.6% | $27.44 | +35.8% | COM | N44821101 |
| XBI | SPDR SERIES TRUST | 925,000 | $83.75M | 5.7% | — | — | Put | 78464A870 |
| — | MIRATI THERAPEUTICS INC | 1,075,000 | $78.8M | 5.3% | $19.29 | — | COM | 60468T105 |
| ASND | ASCENDIS PHARMA A S | 600,000 | $70.62M | 4.8% | $76.66 | — | SPONSORED ADR | 04351P101 |
| APLS | APELLIS PHARMACEUTICALS INC | 3,600,000 | $70.2M | 4.7% | $15.50 | +1.4% | COM | 03753U106 |
| ANAB | ANAPTYSBIO INC | 920,000 | $67.21M | 4.5% | $39.24 | +75.9% | COM | 032724106 |
| — | BIOHAVEN PHARMACTL HLDG CO L | 1,100,000 | $56.62M | 3.8% | $40.54 | — | COM | G11196105 |
| — | REATA PHARMACEUTICALS INC-A | 615,000 | $52.56M | 3.6% | $43.48 | — | CL A | 75615P103 |
| — | PRINCIPIA BIOPHARMA INC | 1,411,898 | $48.01M | 3.2% | $29.22 | — | COM | 74257L108 |
| — | QUOTIENT LTD | 4,600,000 | $41.45M | 2.8% | $8.95 | — | SHS | G73268107 |
| — | TRICIDA INC | 1,009,586 | $38.99M | 2.6% | $32.30 | — | COM | 89610F101 |
| — | BLUEPRINT MEDICINES CORP | 450,000 | $36.02M | 2.4% | $69.23 | — | COM | 09627Y109 |
| SRPT | SAREPTA THERAPEUTICS INC | 300,000 | $35.76M | 2.4% | $127.51 | +0.8% | COM | 803607100 |
| — | CHEMOCENTRYX INC | 2,525,900 | $35.09M | 2.4% | $13.89 | — | COM | 16383L106 |
| GLPG | GALAPAGOS NV | 300,000 | $34.97M | 2.4% | $116.55 | — | SPON ADR | 36315X101 |
| ARGX | ARGENX SE | 275,000 | $34.33M | 2.3% | $82.17 | — | SPONSORED ADR | 04016X101 |
| CRSP | CRISPR THERAPEUTICS AG | 900,000 | $32.15M | 2.2% | $34.60 | -0.1% | NAMEN AKT | H17182108 |
| — | MYOKARDIA INC | 600,000 | $31.19M | 2.1% | $17.38 | — | COM | 62857M105 |
| — | AXONICS MODULATION TECH INC | 1,272,495 | $30.48M | 2.1% | $15.11 | — | COM | 05465P101 |
| — | ALLAKOS INC | 750,000 | $30.38M | 2.1% | $42.85 | — | COM | 01671P100 |
| RCKT | ROCKET PHARMACEUTICALS INC | 1,700,000 | $29.82M | 2.0% | $16.37 | -3.6% | COM | 77313F106 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 850,000 | $26.75M | 1.8% | $31.47 | — | SPON ADS | 05280R100 |
| — | ZOGENIX INC | 450,000 | $24.75M | 1.7% | $49.31 | — | COM NEW | 98978L204 |
| KURA | KURA ONCOLOGY INC | 1,400,000 | $23.23M | 1.6% | $14.56 | +5.8% | COM | 50127T109 |
| — | KEZAR LIFE SCIENCES INC | 1,300,000 | $23.06M | 1.6% | $17.30 | — | COM | 49372L100 |
| — | ATARA BIOTHERAPEUTICS INC | 550,000 | $21.86M | 1.5% | $39.75 | — | COM | 046513107 |
| — | SAGE THERAPEUTICS INC | 130,000 | $20.68M | 1.4% | $161.07 | — | COM | 78667J108 |
| — | Y-MABS THERAPEUTICS INC | 715,482 | $18.75M | 1.3% | $26.31 | — | COM | 984241109 |
| — | CONSTELLATION PHARMACEUTICALS I | 1,271,687 | $17.23M | 1.2% | $6.73 | — | COM | 210373106 |
| — | NEKTAR THERAPEUTICS | 500,000 | $16.8M | 1.1% | $69.99 | — | COM | 640268108 |
| TWST | TWIST BIOSCIENCE CORP | 706,064 | $16.37M | 1.1% | $22.16 | +2.0% | COM | 90184D100 |
| — | MYOVANT SCIENCES LTD | 650,000 | $15.52M | 1.0% | $23.87 | — | COM | G637AM102 |
| INSP | INSPIRE MED SYS INC | 250,000 | $14.2M | 1.0% | $32.28 | +67.4% | COM | 457730109 |
| GOSS | GOSSAMER BIO INC | 653,129 | $14.15M | 1.0% | $20.85 | 0.0% | COM | 38341P102 |
| — | PRECISION BIOSCIENCES INC | 780,018 | $14M | 0.9% | $17.95 | — | COM | 74019P108 |
| — | AMARIN CORP PLC | 600,000 | $12.46M | 0.8% | $15.51 | — | SPONS ADR NEW | 023111206 |
| — | ARRAY BIOPHARMA INC | 500,000 | $12.19M | 0.8% | $6.75 | — | COM | 04269X105 |
| — | EIDOS THERAPEUTICS INC | 507,564 | $11.9M | 0.8% | $20.31 | — | COM | 28249H104 |
| — | RUBIUS THERAPEUTICS INC | 650,000 | $11.77M | 0.8% | $21.38 | — | COM | 78116T103 |
| — | ORCHARD THERAPEUTICS PLC | 650,143 | $11.63M | 0.8% | $16.64 | — | ADS | 68570P101 |
| — | ARENA PHARMACEUTICALS INC | 250,000 | $11.21M | 0.8% | $42.46 | — | COM NEW | 040047607 |
| ZLAB | ZAI LAB LTD | 350,000 | $10.33M | 0.7% | $22.58 | — | ADR | 98887Q104 |
| — | RA PHARMACEUTICALS INC | 400,000 | $8.96M | 0.6% | $18.20 | — | COM | 74933V108 |
| GNFTY | GENFIT S A | 350,000 | $8.4M | 0.6% | $24.00 | — | ADS | 372279109 |
| — | PHASEBIO PHARMACEUTICALS INC | 839,642 | $7.985M | 0.5% | $3.09 | — | COM | 717224109 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 90,000 | $7.929M | 0.5% | $31.24 | +167.5% | COM | 64125C109 |
| — | AVROBIO INC | 300,000 | $6.615M | 0.4% | $28.56 | — | COM | 05455M100 |
| — | HARPOON THERAPEUTICS INC | 673,891 | $6.382M | 0.4% | $9.47 | — | COM | 41358P106 |
| — | KINIKSA PHARMACEUTICALS LTD | 270,000 | $4.876M | 0.3% | $16.66 | — | COM CL A | G5269C101 |
| — | MINERVA NEUROSCIENCES INC | 607,903 | $4.778M | 0.3% | $7.26 | — | COM | 603380106 |
| — | TRANSLATE BIO INC | 454,549 | $4.632M | 0.3% | $12.65 | — | COM | 89374L104 |
| — | X4 PHARMACEUTICALS INC | 252,749 | $4.4M | 0.3% | $17.41 | — | COM | 98420X103 |
| — | AUDENTES THERAPEUTICS INC | 100,000 | $3.902M | 0.3% | $18.38 | — | COM | 05070R104 |
| HRTX | HERON THERAPEUTICS INC | 150,000 | $3.666M | 0.2% | $15.72 | +66.5% | COM | 427746102 |
| SRRK | SCHOLAR ROCK HLDG CORP | 178,891 | $3.361M | 0.2% | $18.88 | -6.8% | COM | 80706P103 |
| — | ITERUM THERAPEUTICS PLC | 398,300 | $3.198M | 0.2% | $10.89 | — | SHS | G6333L101 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | 200,000 | $3.028M | 0.2% | $17.28 | -7.3% | COM | 19459J104 |
| — | ABEONA THERAPEUTICS INC | 400,000 | $2.944M | 0.2% | $8.20 | — | COM | 00289Y107 |
| INCY | INCYTE CORP | 30,000 | $2.58M | 0.2% | $68.44 | +18.9% | COM | 45337C102 |
| ACRS | ACLARIS THERAPEUTICS INC | 420,555 | $2.519M | 0.2% | $19.94 | -66.8% | COM | 00461U105 |
| — | SOLID BIOSCIENCES INC | 250,000 | $2.3M | 0.2% | $7.49 | — | COM | 83422E105 |
| — | ACCELERON PHARMA INC | 40,000 | $1.863M | 0.1% | $32.04 | — | COM | 00434H108 |
| — | OUTLOOK THERAPEUTICS INC | 416,666 | $150K | 0.0% | $0.15 | — | *W EXP 02/18/202 | 69012T115 |
| — | CELLECTAR BIOSCIENCES-CW19 | 52,999 | $5,000 | 0.0% | $0.55 | — | *W EXP 08/20/201 | 15117F120 |